R & D
Our research mission is to develop the safe, effective and marketable drugs for pulmonary arterial hypertension and further drug-eluting stents.
We are 4 employees, whose specialties include enzyme kinetics, cell function study, and animal model study. Our team is small but has a strong backgrounds of biochemistry, cell biology, and veterinary science.
Therefore, they comprise a streamline for evaluating candidate compounds in in vitro and in vivo systems.